GUJTHEM vs QMSMEDI: Stock Comparison

Gujarat Themis Biosyn Limited vs QMS Medical Allied Services Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Gujarat Themis Biosyn Limited shows a higher ROE, faster revenue growth and lower leverage, while QMS Medical Allied Services Ltd shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Gujarat Themis Biosyn Limited and QMS Medical Allied Services Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GUJTHEM is more favourable on 8 of 13 scored metrics and QMSMEDI on 5These counts are context-free and are not an overall rating.

Key Differences

P/E Ratio
QMSMEDI has a lower P/E
12.43x vs 84.23x
P/B Ratio
QMSMEDI has a lower P/B
1.95x vs 13.65x
EPS
QMSMEDI has higher earnings per share
₹5.24 vs ₹4.27
Dividend Yield
QMSMEDI has a higher dividend yield
0.48% vs 0.18%
Revenue Growth (TTM YoY)
GUJTHEM has faster revenue growth
17.2% vs 0%
EPS Growth (TTM YoY)
QMSMEDI has faster EPS growth
0% vs -9.1%
Qtr Sales Growth
GUJTHEM has stronger quarterly sales growth
17.2% vs -0.36%
Qtr Profit Growth
GUJTHEM has stronger quarterly profit growth
-9.25% vs -48.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGUJTHEMQMSMEDI
SectorHealthcare
IndustryPharmaceuticals

Price

MetricGUJTHEMQMSMEDI
Live Price₹360.5₹110.6
Day Change1.18%2.24%
Volume32,35118,570
52-Week High₹479₹118.7
52-Week Low₹225.05₹98.05
Distance from 52W High-24.74%-6.82%

Valuation

MetricGUJTHEMQMSMEDI
Market Cap₹3,926 Cr
P/E Ratio84.23x12.43x
P/B Ratio13.65x1.95x
EPS₹4.27₹5.24
Book Value₹26.41₹53.9
Dividend Yield0.18%0.48%

Growth

MetricGUJTHEMQMSMEDI
Revenue Growth (TTM YoY)17.2%0%
EPS Growth (TTM YoY)-9.1%0%
Qtr Sales Growth17.2%-0.36%
Qtr Profit Growth-9.25%-48.5%

Profitability & Leverage

MetricGUJTHEMQMSMEDI
ROE17.4%10.4%
ROCE17.9%13.2%
Net Margin28.15%0%
Operating Margin45.6%15%
Debt to Equity0.56x0.65x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricGUJTHEMQMSMEDI
Promoter Holding70.86%68.11%
FII Holding1.8% 0.16 pp0%
DII Holding1.18% 0.01 pp1.59%
Public Holding26.16% 0.16 pp30.3%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Gujarat Themis Biosyn Limited and QMS Medical Allied Services Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.